Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Clinical Trials

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

Exploratory Clinical Trials
NINDS encourages applications for exploratory clinical trials.

This announcement supports proposals for exploratory clinical trials (i.e., phase I and II studies) of drugs, biologics or devices, as well as surgical, behavioral, or rehabilitation therapies, that contribute to the justification for and provide the data required to design a future trial to confi rm efficacy (i.e., a phase III trial). Proposals must aim to generate data that inform a decision whether to continue further clinical development of the proposed intervention.

Application Due Date: July 14, 2010

Potential applicants should contact Peter Gilbert, clinical research project manager, Office of Clinical Research, NINDS, at 301-496-0870 or gilbertp@ninds.nih.gov. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-10-199.html.

Phase III Clinical Trials
NINDS invites applications for phase III investigator-initiated, multi-center clinical trials.

Phase III trials are conducted to provide definitive answers regarding the safety and efficacy of interventions. These trials are the most complex and challenging to design and implement. In addition to lengthy study startup, slow participant enrollment can cause trial delays and result in the need for additional funding in order to complete the planned trials. Preventing trial failure due to poor planning, enrollment, and retention requires anticipatory and flexible management. The purpose of this announcement is to provide a vehicle to submit and successfully implement large, complex phase III clinical trials that include stages to allow the investigators and NINDS to assess study progress and feasibility.

Application Due Date: July 14, 2010

Potential applicants should contact Dr. Scott Janis, clinical research project manager, Office of Clinical Research, NINDS, at 301-496-9135 or sj151t@nih.gov. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-10-198.html.